Epidarex Portfolio News

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY


Category: Epidarex Portfolio News

Glasgow Diabetes Spin-Out Caldan Beefs Up Boardroom

By Gareth Mackie, The Scotsman A university spin-out that specialises in potential treatments for type 2 diabetes has bolstered its boardroom in the wake of a £4.5 million cash injection. Glasgow-based Caldan Therapeutics, a spin-out from the universities of Glasgow and Southern Denmark, has appointed…

Apellis Completes $47 Million Series D Financing

Louisville, Ky., Feb. 12, 2016 – Apellis Pharmaceuticals, Inc., today announced that it has completed a $47.1 million Series D preferred stock financing, co-led by new investors Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund, joining existing investors Morningside Venture Investments, AJU IB…